BMC2 PCI Bibliography
Updated 09/16/2015 -dc
Peer Reviewed Journals and Publications:
2015:
Hitinder S. Gurm, Carrie Hosman, Eric R Bates, David Share, & Ben B. Hansen. Comparative
Effectiveness and Safety of a Catheterization Laboratory-Only Eptifibatide Dosing Strategy in
Patients Undergoing Percutaneous Coronary Intervention. Circ. Intervention. February 2015.
Michael J. Howe, Milan Seth, Arthur Riba, George Hanzel, Mark Zainea & Hitinder S. Gurm. The
Underutilization of Radial Access in Patients Undergoing PCI for STEMI; insights from the Blue
Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Circulation: Cardiovascular
Interventions. March 2015.
Amrita Karve, Milan Seth, Manoj Sharma, Thomas LaLonde, Simon Dixon, David Wohns & Hitinder
Gurm. Contemporary Use of Ticagrelor in Interventional Practice: Insights from Blue Cross
Blue Shield of Michigan Cardiovascular Consortium (BMC2). American Journal of Cardiology.
March 2015.
Jessica Parsh, Milan Seth, Herbert Aronow, Simon Dixon, Michael Heung, Roxana Mehran & Hitinder
Gurm. Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug Dosing
Recommendations and Risk Stratification in Patients with Chronic Kidney Disease Undergoing
Percutaneous Coronary Interventions. JACC, Accepted April 2015.
Jonathan McDonagh, Milan Seth, Thomas Lalonde, M. Reddy, Akshay Khandewal, David Wohns,
Simon Dixon & Hitinder Gurm. Radial PCI and the obesity paradox: Insights from Blue Cross
Blue Shield of Michigan Cardiovascular Consortium (BMC2). CCI (Catheterization and
Cardiovascular Interventions). April 2015
Janey Kooimna, Milan Seth, Brahmajee Nallamothu, Michael Heung, David Humes, and Hitinder S.
Gurm. Association between Acute Kidney Injury and In-Hospital Mortality in Patients
Undergoing Percutaneous Coronary Interventions. Circ. Cardiovascular Interventions. June 2015
2014:
Hussein Othman, Sherezade Khambatta, Milan Seth, Thomas A. Lalonde, Howard S. Rosman,
Hitinder S. Gurm, Rajendra H. Mehta. Differences in sex-related bleeding and outcomes after
percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2) registry. AHJ October 2014
Jeffrey Bruckel, Milan Seth, Richard Prager, Andrea Jensen, Brahmajee Nallamothu, Hitinder Gurm.
Use of a Heart Team in Decision-Making for Patients with Complex Coronary Disease at
Hospitals in Michigan Prior to Guideline Endorsement. PLoS One November 2014
Muthappan Palanianppan, Dean Smith, Herbert Aronow, Kim Eagle, David Wohns, James Fox, David
Share, and Hitinder S Gurm. The Epidemiology and Outcomes of Percutaneous Coronary
Intervention before High-Risk Noncardiac Surgery in Contemporary Practice: Insights from the
Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry. J Am Heart
Assoc. 2014;3:e000388
Gurm HS, Kooiman J, Lalonde T, Grines C, Share D, Seth M.. Random Forest Based Risk Model
for Reliable and Accurate Prediction of Receipt of Transfusion in Patients Undergoing
Percutaneous Coronary Intervention. PLoS ONE 9(5): e96385. doi:10.1371/journal.pone.0096385
Mohamad Kenaan, Milan Seth, Herbert Aronow, Joseph Naoum, Stephen Peck, Douglas Wunderly,
Dale Leffler, James Mitchiner, Mauro Moscucci and Hitinder S. Gurm. Pre-procedural Statin Use in
Patients Undergoing Percutaneous Coronary Intervention. American Heart Journal
Judith Kooiman, Milan Seth, Simon Dixon, David Wohns, Thomas LaLonde, Sunil V Rao and
Hitinder S. Gurm. Risk of Acute Kidney Injury After Percutaneous Coronary Interventions Using
Radial Versus Femoral Vascular Access: Insights From the Blue Cross Blue Shield of Michigan
Cardiovascular Consortium. Circ Cardiovasc Interv. February 2014.
Judith Kooiman, Milan Seth, David Share, Simon Dixon, Hitinder S. Gurm. The Association between
Contrast Dose and Renal Complications Post PCI across the Continuum of Procedural
Estimated Risk. PLoS ONE 9(3): March 13, 2014
Amneet Sandhu, Milan Seth, Hitinder S Gurm. Daylight Savings Time and Myocardial Infarction.
Open Heart 2014;1: March 29, 2014
2013:
John R. Hoyt, MD, Milan Seth, MS, Ivan Hanson, MD, Simon Dixon, MD, David Share, MD,
MPH,Thomas Lalonde, MD, David Wohns, MD, Mauro Moscucci, MD, MBA, and Hitinder S. Gurm,
MD. Outcome of Percutaneous Coronary Intervention following Recent Surgery. Am J Cardiol, 2013:
Mohamad Kenaan, MD, Milan Seth, MS, Herbert D. Aronow, MD, MPH, David Wohns, MD, David
Share, MD, Hitinder S. Gurm, MD. The Clinical Outcomes of Percutaneous Coronary Intervention
Performed Without Pre-Procedural Aspirin. JACC December 2013;62(22);2083-9
Hitinder S. Gurm, MD, Carrie Hosman, PhD, David Share, MD, Mauro Moscucci, MD, and Ben B.
Hansen, PhD. Comparative Safety of Vascular Closure Devices and Manual Closure Among
Patients Having Percutaneous Coronary Intervention. Ann Intern Med. November 2013;159:660666.
Emily Perdoncin, Min Zhang, Arthur Riba, Thomas A. LaLonde, Cindy L. Grines and Hitinder S.
Gurm. Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and
Platelet Glycoprotein IIb/IIIa Inhibitors: Insights From Blue Cross Blue Shield of Michigan
Cardiovascular Consortium. Circ Cardiovasc Interv December 2013.
Amneet Sandhu, MD; Mauro Moscucci, MD, MBA; Simon Dixon, MD; David Wohns, MD; David
Share, MD, MPH; Thomas LaLonde, MD; Dean Smith, PhD; and Hitinder S. Gurm, MBBS.
Differences in the outcome of patients undergoing percutaneous coronary interventions at
teaching versus non-teaching hospitals. American Heart Journal, published August 1, 2013.
Michael E. Buschur, MD; Dean Smith, PhD, MPH; David Share, MD; William Campbell, MD;
Stephen Mattichak, MD; Manoj Sharma, MD; Hitinder S. Gurm, MD. The Burgeoning Epidemic of
2
Morbid Obesity in Patients Undergoing Percutaneous Coronary Intervention: Insight From the
Blue Cross Blue Shield of Michigan Cardiovascular Consortium. JACC, August 20, 2013:685–91
Hitinder S. Gurm, MD, Milan Seth, MS, Judith Kooiman, MSc, David Share, MD. A Novel Tool for
Reliable and Accurate Prediction of Renal Complications in Patients Undergoing Percutaneous
Coronary Intervention. JACC, June 4, 2013:2242–8.
Larsen GK, Seth M, Gurm HS., The Ongoing Importance of Smoking as a Powerful Risk Factor
for ST-Segment Elevation Myocardial Infarction in Young Patients. JAMA Intern Med. 2013 May
27:1-2. doi: 10.1001/jamainternmed.2013.6075.
Amer K. Ardati, MD, Bertram Pitt, MD, Dean E. Smith, PhD, MPH, Herbert D. Aronow, MD, MPH,
David Share, MD, Mauro Moscucci, MD, MBA, Stanley Chetcuti, MD, P. Michael Grossman, MD,
Hitinder S.Gurm, MD. Current medical management of stable coronary artery disease before and
after elective percutaneous coronary intervention. Am Heart J, 2013;0:1-7.
Sherezade Khambatta, DO, MHA, Milan Seth, MS, Howard S. Rosman, MD, David Share, MD,
MPH, Herbert D. Aronow, MD, MPH, FACC, Mauro Moscucci, MD, MBA, Thomas LaLonde, MD,
Simon R. Dixon, MBChB, FACC, Hitinder S. Gurm, MD, FACC. The association between patient
race, treatment, and outcomes of patients undergoing contemporary percutaneous coronary
intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
(BMC2). Am Heart J, 2013;0:1-9.e1.
Amneet Sandhu, MD; Milan Seth, MS; Simon Dixon, MD; David Share, MD, MPH;
David Wohns, MD; Thomas LaLonde, MD; Mauro Moscucci, MD, MBA; Arthur L. Riba, MD;
Michael Grossman, MD; Hitinder S. Gurm, MBBS. Contemporary Use of Prasugrel in Clinical
Practice Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
Circ Cardiovasc Qual Outcomes, published online May 14, 2013;
Hitinder S Gurm, MD; Dean Smith, PhD, MPH; David Share, MD; David Wohns, MD; John
Collins MD; Mohan Madala, MD; Srinivas Koneru, MD; Dan Menees, MD; Stanley
Chetcuti, MD. Impact of Automated Contrast Injector Systems on Contrast Use and Contrast
Associated Complications in Patients Undergoing Percutaneous Coronary Interventions.
JACC Cardiovasc Interv. April 2013
Javier A. Valle, MD; Min Zhang, Ph.D.; Simon Dixon, MBChB; Herbert D. Aronow, MD, MPH;
David Share,MD, MPH; Joseph B. Naoum, MD; Hitinder S. Gurm, MBBS, Impact of PreProcedural Beta Blockade on Inpatient Mortality in Patients Undergoing Primary Percutaneous
Coronary Intervention for ST elevation Myocardial Infarction American Journal of Cardiology.
(To be published online, JACC Cardiovasc Interv. June 2013).
2012:
Cause and Circumstance of In-Hospital Mortality Among Patients Undergoing Contemporary
Percutaneous Coronary Intervention: A Root-Cause Analysis
Javier A. Valle, MD; Dean E. Smith, PhD, MPH; Anna M. Booher, MD; Daniel S. Menees, MD;
Hitinder S. Gurm, MD. Circ Cardiovasc Qual Outcomes. 2012;5:00-00.
3
Javier Valle, Dean E. Smith, Stephen G. Ellis, Hitinder S Gurm, Eroding the denominator: the
incomplete story of Door-to-Balloon Time Reporting. Research Letter; J Am Coll Cardiol,
doi:10.1016/j.jacc.2012.02.047 (Published online 30 May 2012)
Nicklaus K Slocum, MD, P Michael Grossman, MD, Mauro Moscucci, MD, Dean E Smith, PhD,
MPH, Herbert D. Aronow, MD, MPH, Simon R. Dixon, MBChB, David Share, MD, Hitinder S Gurm,
MD, The Changing Definition of Contrast Induced Nephropathy and Its Clinical Implications:
Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Am Heart J. 2012 May;163(5):829-34. PMID: 22607861
Hitinder S. Gurm, MD, Dean E. Smith, PhD, MPH, Otavio Berwanger, MD, David Share, MD,
Theodore Schreiber MD, Mauro Moscucci, MD, MBA, Brahmajee K. Nallamothu, MD, MPH, for
the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Contemporary use and
effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy among patients
undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2012 Jan;5(1):98-104.
2011:
Hitinder S. Gurm, MD, Simon R. Dixon, MBChB, Dean E. Smith, PhD, MPH, David Share, MD,
Thomas LaLonde, MD, Adam Greenbaum, MD and Mauro Moscucci, MD, MBA, for the Blue Cross
Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry, Renal function based contrast
dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous
coronary interventions. JACC. Vol. 58, No. 9, 2011:907–14.
Michael P. Thomas, MD, Mauro Moscucci, MD, Dean E. Smith, PhD, MPH, Herb Aronow, MD,
MPH, David Share, MD, MPH, Phillip Kraft, MD, Hitinder S Gurm, MD. Outcome of
contemporary percutaneous coronary intervention in the elderly and the very elderly; Insights
from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2), Clinical
Cardiology. Clin Cardiol. 2011 Sep;34(9):549-54.
Elizabeth A. Jackson, MD MPH, Mauro Moscucci, MD, MBA, Dean E. Smith, PhD, MPH
David Share, MD, Simon Dixon. MBChB, Adam Greenbaum, MD , Paul M. Grossman, MD, Hitinder
S. Gurm, MD. The Association of Sex with Outcomes Among Patients Undergoing Primary PCI
for STEMI In The Contemporary Era: Insights From The Blue Cross Blue Shield Of Michigan
Cardiovascular Consortium (BMC2) Am Heart J. 2011;161:106-112.e1
2010:
Krishna G. Aragam, AB, Mauro Moscucci, MD, MBA, Dean E. Smith, PhD, Arthur L. Riba, MD,
Mark Zainea, MD, James L. Chambers, MD, David Share, MD, Hitinder S. Gurm, MBBS. Trends
and Disparities in Referral to Cardiac Rehabilitation After Percutaneous Coronary Intervention.
Am Heart J. 2010;0:1-8.e2.
Reed MC, Moscucci M, Smith DE, Share D, LaLonde T, Mahmood SA, D’Haem C, McNamara R,
Greenbaum A, Gurm HS. The Relative Renal Safety of Iodixanol and Low-Osmolar Contrast
Media in Patients Undergoing Percutaneous Coronary Intervention: Insights From Blue Cross
Blue Shield of Michigan Cardiovascular Consortium (BMC2). Journal of Invasive Cardiology,
2010;22:467–472.
4
Santi Trimarchi, MD, Dean E. Smith, PhD, David Share, MD, MPH, Sandeep M. Jani, MPH, Michael
O'Donnell, MD, FACC, Richard McNamara, MD, FACC, Arthur Riba, MD,FACC, Eva KlineRogers, RN, Hitinder S. Gurm, M.D., FACC, Mauro Moscucci, MD, FACC†. Retroperitoneal
Hematoma After Percutaneous Coronary Intervention: Prevalence, Risk Factors, Management,
Outcomes and Predictors of Mortality. A report From The Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2) Registry. J. Am. Coll. Cardiol. Intv. 2010; 3; 845-850.
Anneliese Flynn, MD; Mauro Moscucci, MD, MBA; David Share, MD, MPH; Dean Smith, PhD,
MPH; Thomas LaLonde, MD; Hameem Changezi, MD; Arthur Riba, MD; Hitinder S. Gurm, MBBS
Trends in Door to Balloon Time and Mortality in Patients with ST-Elevation Myocardial
Infarction Undergoing Primary Percutaneous Coronary Intervention. Arch Intern Med.
2010;170(20):1842-1849.
Claire S. Duvernoy, MD, Dean E Smith, PhD, MPH, Prerana Manohar, MD, Ann Schaefer, MS, RN,
Eva Kline-Rogers, MS, RNP, David Share, MD, MPH, Richard McNamara, MD, Hitinder S. Gurm,
MD, Mauro Moscucci, MD, MBA. Gender Differences in Adverse Outcomes Following
Contemporary PCI: An Analysis from the Blue Cross Blue Shield of Michigan Cardiovascular
Consortium (BMC2) Percutaneous Coronary Intervention Registry . Am Heart J. 2010 Apr;
159(4):677-683.e1.
Gualano SK, Gurm HS, Share D, Smith DE, Aronow HD, Lalonde T, Bates ER, Changezi H,
McNamara R, Moscucci M. Temporal Trends in the Use of Drug-eluting Stents for Approved and
Off-label Indications: A Longitudinal Analysis of a Large Multicenter Percutaneous Coronary
Intervention Registry. Clin. Cardiol, 33, 2, 111-116, 2010.
2009:
Grossman PM, Gurm HS, McNamara R, Lalonde T, Changezi H, Share D, Smith DE, Chetcuti SJ,
Moscucci M. Percutaneous Coronary Intervention Complications and Guide Catheter Size:
Bigger is Not Better. JACC Interventions, 2009; 2 (7):636-44.
2008:
Gurm HS, Smith DE, Collins SJ, Share D, Riba A, Carter AJ, LaLonde T, Kline-Rogers EM,
O’Donnell M, Changezi H, Zughaib M, Safian R, and Moscucci M. The Relative Safety and
Efficacy of Abciximab and Eptifibatide in Patients Undergoing Primary Percutaneous Coronary
Intervention: Insights From A Large Regional Registry of Contemporary Percuteneous
Coronary Intervention. J Amer Coll Card., 2008; 51 (5): 529-535.
2007:
Gurm HS, Smith DE, Chetcuti SJ, Share D, Khanal S, Riba A, Carter AJ, LaLonde T, Kline-Rogers
EM, O’Donnell M, O’Neill WO, Safian R, and Moscucci M. Temporal Trends, Safety, and Efficacy
of Bivalirudin in Elective Percutaneous Coronary Intervention: Insights from the Blue Cross
Blue Shield of Michigan Cardiovascular Consortium. J Interven Cardio., 2007; 20: 197-203.
Chetcuti SJ, Grossman PM, Kline-Rogers EM, Montoye C, Smith DE and Moscucci M. Improving
Outcomes of Percutaneous Coronary Intervention through the Application of Guidelines and
Benchmarking: Reduction of Major Bleeding and Blood Transfusion as a Model. Clin. Cardiol.,
2007; 30 (Suppl. II), II-44 – II-48.
5
Jani SM, Smith DE, Share DM, Kline-Rogers EM, Khanal S, O'Donnell M, Gardin J, and Moscucci M.
Blood Transfusion and In-Hospital Outcomes in Anemic Patients with Myocardial Infarction
Undergoing Percutaneous Coronary Intervention. Clin. Cardiol. 2007; 30 (Suppl. II): II-49 – II56.
2006:
Moscucci M, Share D. Impact of Health Care Initiatives on Outcomes of Acute Coronary
Syndromes. Heart 2006; 92:293-295.
Lins S, RN, Guffey D, RN, Kline-Rogers E, MS, RN, VanRiper S, MS, RN. Decreasing Vascular
Complications following Percutaneous Coronary Interventions: Partnering to improve
outcomes. Critical Care Nurse, 2006;26 (6): 38-45.
Moscucci M, MD, Kline Rogers E, RN, MS, Montoye C, RN, MN, Smith DE, MS, PhD, Share D,
MD, MPH, O’Donnell M, MD, Maxwell-Eward A, PhD, Meengs WL, MD, De Franco AC, MD,
Chambers JL, MD, Patel K, MD, McGinnity JG, MS, PA-C, Khanal S, MD, Eagle KA, MD, For the
Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Association of a
Continuous Quality Improvement Initiative With Practice and Outcome Variations of
Contemporary Percutaneous Coronary Interventions. Circulation, 2006;113:814-822.
Moscucci M, Eagle KE., Door-to-Balloon Time in Primary Percutaneous Coronary Intervention,
Is the 90-minute Gold Standard an Unreachable Chimera? Circulation, 2006;113:1048-1050.
Moscucci M, Eagle KE., Reducing the Door-to-Balloon Time for Myocardial Infarction with STSegment Elevation. NEJM, 2006;355:22.
2005:
Khanal S, MD, Henry Ford Heart and Vascular Institute, Detroit, MI. Attallah N, MD; Henry Ford
Hospital, Detroit, MI. Smith DE, PhD; University of Michigan, Ann Arbor, MI. Kline-Rogers E, RN;
University of Michigan, Ann Arbor, MI. Share D, MD; Blue Cross Blue Shield of Michigan, MI.
.O’Donnell MJ, MD; St. Joseph Mercy Hospital, Ann Arbor, MI. Moscucci M, MD; University of
Michigan, Ann Arbor, MI. Statin Therapy Reduces Contrast-Induced Nephropathy. An Analysis
from a Large Regional Registry of Contemporary Percutaneous Interventions. American Journal
of Medicine 2005;118:843-849.
Aboufakher R, MDa, Riba A, MDa, Jani SM, BSb, Goswami R, MDa, Shwartz S, PhDa, Lins S, RNa,
Gardin Jc, Smith DE, MS, PhDb, Kline-Rogers E, RN, MSb, Share D, MD, MPHd, Moscucci M,
MDb, for The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2), University of
Michigan Medical Center, Ann Arbor, MI. Incidence, Risk Factors and Prognosis of Congestive
Heart Failure after Percutaneous Coronary Intervention – Insights from the Blue Cross/Blue
Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J 2005;150:455-8.
Moscucci M, MD, Smith DE, PhD, DeFranco AC, MD, O'Donnell MJ, MD, Meengs WL, MD,
Maxwell-Eward A, PhD, McGinnity JG, Patel K, MD, Share D, MPH, MD, Eagle KA, M.D.
Relationship Between Operator Volume and Adverse Outcome In Contemporary Percutaneous
Coronary Intervention Practice: An Analysis of a Quality Controlled Multicenter Percutaneous
Coronary Intervention Clinical Database. J Am Coll Cardiol 2005;46:625-32.
6
Moscucci M, MD, Eagle KA, MD, Share D, MD, MPH, Smith DE, PhD, De Franco AC, MD, Vakili
BA, MD, Clark VL, MD, Slater JN, MD, Sherman W, MD, Ravi KL, MD, Sanborn TA, MD, Green
SJ, MD, Brown DL, MD. University of Michigan Health System (MM, KAE); Blue Cross Blue Shield
Center for Health Care Quality (DS); McLaren Regional Medical Center (ACD); Henry Ford Hospital
(VLC); Albert Einstein College of Medicine/Montefiore Medical Center. Public Reporting and Case
Selection for Percutaneous Coronary Interventions: An Analysis from Two Large Multicenter
PCI Databases. J Am Coll Cardiol 2005;45:1759-65.
2004:
McKechnie RS, Smith D, Montoye C, Kline-Rogers E, O'Donnell MJ, DeFranco AC, Meengs WL,
McNamara R, McGinnity JG, Patel K, Share D, Riba A, Khanal S, Moscucci M, for the Blue Cross
Blue Shield of Michigan Cardiovascular Consortium (BMC2). Prognostic Implication of Anemia on
In-Hospital Outcomes after Percutaneous Coronary Intervention. Circulation. 110(3):271-7,
2004.
Mukherjee D, Fang F, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KE, Impact of Combination
Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes.
Circulation. 109:745-749, 2004.
2003:
Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, Chetcuti S, Grossman PM, Nallamothu B,
O’Donnell M, DeFranco A, Maxwell-Eward A, McGinnity J, Meengs WL, Patel K, Moscucci M on
behalf of the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium (BMC2). Impact of
Extracardiac Vascular Disease on Acute Prognosis in Patients who Undergo Percutaneous
Coronary Interventions (Data from the Blue Cross & Blue Shield of Michigan Cardiovascular
Consortium ([BMC2). American Journal of Cardiology. 92:972-974, 2003.
Moscucci M, O’Donnell M, Share D, Maxwell-Eward A, Kline-Rogers E, DeFranco AC, Meengs,
WL, Clark VL, McGinnity JG, DeGregorio M, Patel K, Eagle KE. Frequency and Prognosis of
Emergency Coronary Artery Bypass Grafting After Percutaneous Coronary Intervention for
Acute Myocardial Infarction. American Journal of Cardiology. 92:967-969, 2003.
2002:
Moscucci M, Share D, Kline-Rogers E, O’Donnell M, Maxwell-Eward A, Meengs WL, Clark V, Kraft
P, De Franco AC, Chambers JL, Patel K, McGinnity JG, Eagle K, for the Blue Cross Blue Shield of
Michigan Cardiovascular Consortium (BMC2). The Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2) Collaborative Quality Improvement Initiative in
Percutaneous Coronary Interventions. J Interventional Cardiology, 15:381-386, 2002.
Kline-Rogers E, Share D, Bondie D, Rogers B, Karavite D, Kanten S, Wren P, Bodurka C, Fisk C,
McGinnity J, Wright S, Lucarelli C, Eagle, KA, Moscucci M, for the Blue Cross Blue Shield of
Michigan Cardiovascular Consortium (BMC2). Development of a Multi-Center Interventional
Cardiology Database: The Blue Cross Blue Shield of Michigan Cardiovascular Consortium
(BMC2) Experience. J Interven Cardiol, 15:387-392, 2002.
Freeman RV, O’Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle
KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M. The Blue Cross Blue Shield
of Michigan Cardiovascular Consortium (BMC2). Nephropathy Requiring Dialysis after
7
Percutaneous Coronary Intervention and the Critical Role of an Adjusted Contrast Dose.
American Journal of Cardiology, 90:1068-1073, 2002.
2001:
Moscucci M, Share D, Kline-Rogers E, O’Donnel MO, Maxwell-Eward A, Meengs WL, Chambers JL,
Kraft P, DeFranco AC, Chambers JL, Patel K, McGinnity JG, Eagle KA. Simple Bedside Additive
Tool for Prediction of In-Hospital Mortality after Percutaneous Coronary Interventions.
Circulation, 104:263-268, 2001.
1999:
Moscucci M, O’Connor GT, Ellis SG, Malenka DJ, Sievers J, Bates ER, Muller DWM, Werns SW,
Kline-Rogers E, Karavite D, Eagle KA. Validation of Risk Adjustment Models for In-Hospital
Percutaneous Transluminal Coronary Angioplasty Mortality on an Independent Data Set. JACC
Vol 34., no 3, 1999.
1998:
Moscucci M, Ricciardi M, Eagle KA, Kline-Rogers E, Bates ER, Werns SW, Karavite D, Muller
DWM. Frequency, Predictors, and Appropriateness of Blood Transfusion After Percutaneous
Coronary Interventions. Am J Cardiol 1998; 81:702-707.
Abstracts:
2015 Abstracts presented at ACC:
Marta Bande, Milan Seth & Hitinder Gurm. The Younger the Better? Clinical Characteristics and
In-Hospital Outcomes of Percutaneous Coronary Intervention Procedures Performed in Patients
45 Years Old or Younger.
Nadia Sutton, Milan Seth, Arthur Riba, Mark Zainea, Cyril Ruwende & Hitinder Gurm. Atrial
Fibrillation is a Strong and Independent Predictor of Poor Outcome among Patients Undergoing
Percutaneous Coronary Intervention: Findings from the Blue Cross Blue Shield of Michigan
Cardiovascular Consortium.
Amrita Karve, Milan Seth, Manoj Sharma, Thomas LaLonde, Simon Dixon, David Wohns & Hitinder
Gurm. Contemporary Use of Ticagrelor in the community: insights from the Blue Cross Blue
Shield of Michigan Cardiovascular Consortium (BMC2).
Jessica Parsh, Milan Seth, Simon Dixon & Hitinder Gurm. Choice of Estimated Glomerular
Filtration Rate Equation Impacts Drug Dosing Recommendations and Risk Stratification in
Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions.
Emily Perdoncin, Milan Seth & Hitinder Gurm. The Comparative Efficacy of Bivalirudin Is
Markedly Attenuated by Use of Radial Access: Insights from Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2).
8
2014 Abstracts presented at SCAI (Las Vegas):
Michael Howe and Hitinder Gurm. The Underutilization of Radial Access During PCI for STEMI;
Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Jason Weingart and Hitinder Gurm. Outcome of Primary PCI with and without Cardiac Surgical
Backup in Michigan: Insights from the BMC2 registry.
2014 Abstracts presented at ACC:
Marta Bande, Milan Seth, Dan Menees, Simon Dixon, Cindy Grines, David Wohns, James Mitchiner
and Hitinder S. Gurm. Manual Aspiration Thrombectomy (MAT) Does Not Impact Short or Long
Term Survival in Primary PCI: Insights from the Blue Cross Blue Shield of Michigan
Cardiovascular Collaborative (BMC2).
Mohamad Kenaan, Milan Seth, Herb Aronow, Joe Naoum, Stephen Peck, Douglas Wunderly, Dale
Leffler and Hitinder S. Gurm. Lack of Statin Use Prior to Percutaneous Coronary Intervention is
Common and is Associated with Increased Rates of Post-Procedural Myocardial Infarction.
Jonathan McDonagh, Milan Seth, Thomas LaLonde, M. Reddy, Akshay Khandelwal, David Wohns,
Simon Dixon and Hitinder S. Gurm. Does Radial PCI Negate the Obesity Paradox: Insights from
BMC2.
Amneet Sandhu, Milan Seth and Hitinder S. Gurm. The Impact of Daylight Savings Time on the
Timing and Incidence of Patients Undergoing Percutaneous Coronary Intervention for Acute
Myocardial Infarction.
Hussien Othman, Sherezade Khambatta, Milan Seth, Thomas LaLonde, Howard Rosman, Hitinder S.
Gurm, Rajendra Mehta. Bleeding Imparts a Greater Mortality Hazard in Women Compared With
Men: Insights From The Blue Cross Blue Shield of Michigan Cardiovascular Consortium
Registry.
Hitinder S. Gurm, Milan Seth, Mohamad Kenaan, Stanley Checuti, Simon Dixon, David Share, P.M.
Grossman and Mauro Moscucci. The Comparative Effectiveness of Bivalirudin and Platelet
Glycoprotein IIbIIIa Inhibitors among Patients Undergoing Contemporary Primary PCI:
Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Collaborative (BMC2).
Prashanth Katrapati, Marta Bande, Milan Seth, Samer Kazziha, Mark Zainew, Simon Dixon, David
Wohns, James Mitchiner and Hitinder S. Gurm. The Untoward Consequences of Heparin Use in
Primary Percutaneous Coronary Intervention; Insights From the Blue Cross Blue Shield of
Michigan Cardiovascular Consortium.
2013 Abstracts presented at AHA:
??? Judith Kooiman, Milan Seth, Sunil Rao, Thomas LaLonde, David Wohns and Hitinder Gurm.
Does Radial Access Reduce the Risk of Contrast Induced Nephropathy in Patients undergoing
9
Percutaneous Coronary Interventions: Insights from the Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2).
2013 Abstracts presented at ACC:
Mohamad Kenaan, Milan Seth, Herbert Aronow, David Wohns, Simon Dixon, David Share and
Hitinder Gurm. Lack of Aspirin Use Prior to Percutaneous Coronary Intervention is Relatively
Common and Strongly Associated with Increased In-hospital Mortality.
Emily Perdoncin, Min Zhang, Arthur Riba, Thomas LaLonde, Cindy Grines, David Share and Hitinder
Gurm. The Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin
and Platelet Glycoprotein IIbIIIa Inhibitors: Insights from Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2).
Gail Larsen , Milan Seth and Hitinder Gurm. The Ongoing Importance of Smoking as a Powerful
Risk Factor for ST-segment Elevation Myocardial Infarction in Young Patients.
John Hoyt, Milan Seth, Ivan Hanson, Simon Dixon, David Share and Hitinder Gurm. Percutaneous
Cornoary Intervention Performed in the Post-operative Period is Associated with High Risk of
Mortality: Insights from the BMC2 Registry.
2012 Abstract presented at AHA:
Javier A. Valle, Min Zhang, David Share, Simon Dixon, Thomas A. Lalonde, Herbert D. Aronow,
Mauro Moscucci, Hitinder S. Gurm; Pre-Procedural Beta Blockade is associated with reduced inpatient mortality following Primary PCI: Insights from the Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2).
Sherezade Khambatta, MI; Milan Seth, Howard S Rosman, Thomas LaLonde, Hitinder S Gurm; The
Influence of Race on Treatment and Outcomes in Patients Undergoing Percutaneous Coronary
Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
Zeeshan Syed, Hitinder S Gurm; Advanced Computational Modeling for Therapeutic DecisionMaking in Patients Undergoing Percutaneous Coronary Intervention: A Focus on
Gastrointestinal Bleeding.
Amneet Sandhu, Milan Seth, Hitinder S Gurm; Prasugrel is Commonly Prescribed to Patients with
Contraindications; Insights from the Blue Cross Blue Shield of Michigan Cardiovascular
Consortium (BMC2).
2012 Abstracts presented at ACC:
Michael E. Buschur, Dean E. Smith, Mauro Moscucci, David Share, William Campbell, Stephen
Mattichak, Manoj Sharma, Hitinder S. Gurm; The Burgeoning Epidemic of Obesity in Patients
Undergoing Percutaneous Coronary Intervention (PCI): Insights from the Blue Cross Blue
Shield of Michigan Cardiovascular Consortium (BMC2) (i2).
10
Muthappan Palaniappan , Dean E. Smith, Herbert Aronow, Kim Eagle, David Wohns, James Fox,
David Share, Hitinder S. Gurm; The Epidemiology and Outcomes of Percutaneous Coronary
Intervention before High Risk Non-Cardiac Surgery: Insights from the BMC2 Registry (i2)
Amneet Sandhu, Mauro Moscucci, Thomas LaLonde, David Share, Simon Dixon, David Wohns, Dean
Smith, Hitinder S. Gurm; Differences in the Outcome of Patients Undergoing Percutaneous
Coronary Interventions at Teaching versus Non-teaching Hospitals (ACC), Young Investigator
Award
Hitinder Gurm, Dean E. Smith, David Share, Bob Applegate; Do automated contrast injectors
reduce contrast use and contrast associated complications: Insights from the Blue Cross Blue
Shield of Michigan Cardiovascular Consortium (BMC2) (i2)
2011 European Society of Cardiology: (Paris, France)
Hitinder S Gurm, Samuel R Kaufman, Dean Smith, Mauro Moscucci, David Share, Ralph Stern
Different risk models predict markedly different probability of death for the same patient:
Implications of using risk models for individual patients. For the Blue Cross Blue Shield of
Michigan Cardiovascular Consortium (BMC2).
Zeeshan Syed, Hitinder S Gurm
Risk stratification for emergency coronary artery bypass graft following percutaneous coronary
intervention. For the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
2011 Society for Cardiac Angiography and Interventions:
Daniel S. Menees, Dean E. Smith, Stanley J. Chetcuti, David Share, Mauro Moscucci, Phillip Kraft,
Hameem Changezi, Hitinder S. Gurm
Thrombectomy Does Not Improve Early Survival in Patients Undergoing Primary PCI for STElevation Myocardial Infarction: Insights From The Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2).
2010 Abstracts Presented at AHA:
Hitinder S. Gurm, Dean Smith, David Share, Thomas Lalonde, Simon Dixon, Adam Greenbaum, Paul
M. Grossman, Mauro Moscucci, For the Blue Cross Blue Shield of Michigan Cardiovascular
Collaborative, University of Michigan, Ann Arbor, MI. Dramatic Underuse of Prasugrel in
Contemporary Practice: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular
Consortium (BMC2).
Amir B. Rabbani, Dean Smith, Mauro Mosccuci, Hitinder S. Gurm, The Blue Cross Blue Shield of
Michigan Cardiovascular Consortium (BMC2)
Trends, Determinants and Implications of Nephropathy associated with Primary PCI: Insights
from the BMC2 Registry.
Hriday Shah, Mauro Moscucci, Dean Smith, (Drs Riba, Chambers and Zainea) David Share, Hitinder
S Gurm. Has the COURAGE Trial Impacted Utilization of Elective Percutaneous Coronary
Intervention (PCI) in Clinical Practice: Insights from the BMC2 Registry.
11
2010 World Congress of Cardiology: (Beijing, China)
Hitinder S. Gurm, Dean Smith, David Share, Mauro Moscucci. Defining the Safe Volume of
Radiographic Contrast in Patients with Abnormal Renal Function: Insights from The Blue
Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
2010 Abstracts Presented at ACC:
Krishna G. Aragam, Mauro Moscucci, David Share, Dean E. Smith, Hitinder S. Gurm. Trends In
Cardiac Rehabilitation Referral Rates For Patients Undergoing Percutaneous Coronary
Intervention: Insights From The BMC2 Registry.
Nicklaus Slocum, Mauro Moscucci, Dean Smith, David Share, Hitinder S Gurm.
The Changing Definition of Contrast Induced Nephropathy and its Clinical Implications:
Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
2009 Abstracts Presented at AHA:
Anneliese Flynn, Mauro Moscucci, David Share, Dean Smith, Thomas Lalonde, Hameem Changezi,
Arthur Riba, Hitinder S. Gurm, For the Blue Cross Blue Shield of Michigan Cardiovascular
Collaborative. Reducing Door to Balloon Time in Patients with ST-Elevation Myocardial
Infarction Undergoing Percutaneous Coronary Intervention: Does a Decrease in Door to
Balloon Time Translate into a Reduction in Mortality?
Yogen Kanthi, Thomas Lalonde, Arthur Riba, Dean Smith, David Share, Mauro Moscucci, Hitinder S.
Gurm. Do Vascular Closure Devices Reduce Vascular Complications in Patients Undergoing
Percutaneous Coronary Interventions: Insights From The Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2).
Elizabeth A. Jackson, Mauro Moscucci, Dean Smith, David Share, Simon Dixon, Adam Greenbaum,
Hitinder S. Gurm. Is Gender Still Relevant to the Outcome of Patients Undergoing Primary PCI
for STEMI in the Contemporary Era? Insights From The Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2).
2008 Abstracts Presented at ACC/i2:
Hitinder S. Gurm, Dean E. Smith, Eva Kline-Rogers, Share David, Michael O'Donnell, Richard
McNamara, Mauro Moscucci. Risk of Death or Emergency Cardiac Surgery in Contemporary
Elective Percutaneous Coronary Interventions; Implications for Percutaneous Coronary
Interventions Without Onsite Bypass Surgery.
Herbert Aronow, Dean Smith, Michael J. O'Donnell, Richard McNamara, Arthur Riba, Hameem
Changezi, Eva Kline-Rogers, David Share, Mauro Moscucci. Frequency and Predictors of
Clopidogrel Pre-treatment in Patients Undergoing Percutaneous Coronary Intervention: A
Report From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium PCI Registry
2007 Abstracts Presented at AHA Outcomes:
12
Erin C Montgomery, Eva Kline-Rogers, Dean Smith, Diane Bondie, Sandra Lins, Patsy Bruenger,
Sharon Van Riper, David Share, Mauro Moscucci. Development of a Quantitative Method to
Evaluate Data Abstraction Validity in a Multi-hospital Quality Improvement Registry
2007 Abstracts Presented at ACC/i2:
Gurm Hitinder, David Share, Dean E. Smith, Thomas LaLonde, Michael O'Donnell, Arthur Riba,
Hameem Changezi, Marcel Zughaib, Harish Chandra, Robert Safian, Mauro Moscucci. Abciximab or
Eptifibatide: Differences in outcomes of Patients Treated with Abciximab versus Eptifibatide as
Adjunct Therapy for Primary Percutaneous Coronary Interventions for ST Elevation
Myocardial Infarction.
Santi Trimarchi, Dean E. Smith, David Share, Michael O'Donnell, Richard McNamara, Arthur Riba,
Eva Kline-Rogers, Mauro Moscucci. Retroperitoneal Hematoma after PCI: Prevalence, Risk
Factors, Predictors, Management and Outcomes. Results from The Blue Cross Blue Shield of
Michigan Cardiovascular Consortium (BMC2) Registry.
2006 Abstracts Presented at AHA:
Sanjaya Khanal, Dean E. Smith, Robert Safian, Julius Gardin, Michael O'Donnell, David Share,
Hameem Changezi, Richard McNamara, Mauro Moscucci. Chronic Renal Insufficiency and
Bleeding Risk after Percutaneous Coronary Intervention: A Continuous rather than a
“Threshold” Relationship
Mauro Moscucci, Dean E. Smith, Herbert D. Aronow, Julius Gardin, Arthur Riba, Robert Safian,
Hameem Changezi, David Share. The critical role of a weight and creatinine adjusted contrast
dose on fatal and non-fatal adverse outcomes of Percutaneous Coronary Intervention.
Mauro Moscucci, Dean E. Smith, Chris D’Haem, Kirit Patel, Thomas LaLonde, Sanjaya Khanal,
Herbert D. Aronow, Arthur Riba, Robert Safian, David Share,
The Effect of Bivalirudin on Bleeding Risk in Patients with Chronic Renal Failure Undergoing
Contemporary Percutaneous Coronary Intervention (PCI): an Analysis From a Large
Multicenter PCI Registry
2006 Abstracts Presented at ACC:
Hitinder Gurm, Dean Smith, Michael O'Donnell, Kirit Patel, Sanjaya Khanal, Thomas Lalonde,
Richard McNamara, David Share, Mauro Moscucci, for The Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2). The Association Between Stent Deployment Pressure And In
Hospital Complications of Contemporary PCI: Insights From a Large Multicenter Registry.
Hitinder Gurm, Dean E. Smith, Sanjaya Khanal, Arthur Riba, Andrew J. Carter, Thomas LaLonde, Eva
M. Kline-Rogers, Mauro Moscucci, University of Michigan Medical Center, Ann Arbor, MI. The
Safety and Efficacy of Elective Percutaneous Coronary Intervention (PCI) Using Bivalirudin
Versus Heparin And Glycoprotein (GP) IIbIIIa Inhibitors: Insights from The Blue Cross Blue
Shield Of Michigan Cardiovascular Consortium (BMC2)
13
Noah J. Jones, Dean E. Smith, Eva Kline Rogers, Sanjaya Khanal, Richard McNamara, Thomas
LaLonde, Michael J O'Donnell, Kirit Patel, David Share, Mauro Moscucci. Predictors of Length of
Hospital Stay After Contemporary Percutaneous Coronary Intervention.
Mauro Moscucci, Dean E. Smith, Eva M. Kline-Rogers, Michael O'Donnell, Kirit Patel, Sanjaya
Khanal, Richard McNamara, David Share, Kim A. Eagle, for The Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2). A Comprehensive Approach to the Development Of Risk
Adjustment Models for Fatal and Non Fatal Outcomes Following Contemporary PCI: A Report
from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
2005 Abstracts Presented at AHA:
Chandra H, McNamara R, Schaefer A, D’Haem C, Hill T, Karve M, DeGregorio M, Smith DE, Share
D, Moscucci M. Treatment with ACE Inhibitors and Angiotensin Receptor Blockers Prior to
Percutaneous Coronary Intervention is Associated with a reduction of Adverse In-Hospital
Outcomes in Patients with Moderate to Severe Renal Impairment.
Moscucci M, Dean Smith, Richard McNamara, Hameem Changezi; Sanjaya Khanal, Chris D’Haem,
Eva Kline-Rogers, Arthur Riba, Julius Gardin, David Share. Relationship between total operator
procedure volume and clinical outcome of PCI for myocardial infarction.
2005 Abstracts Presented at ACC:
Jani SM, Smith DE, Kline-Rogers EM, Khanal S, Lauer MA, O'Donnell M, Share D, Moscucci M.
Effect of Blood Transfusion on In-Hospital Mortality in Anemic Patients with Myocardial
Infarction Undergoing Percutaneous Coronary Interventions.
Tsai T, Smith DE, Kline-Rogers E, D'Haem C, Karve M, Patel K, Moscucci M, University of
Michigan Medical Center, Ann Arbor, MI. The Impact of Clinical Trials of Antithrombotic
Therapy in Patients Undergoing Contemporary Percutaneous Coronary Intervention.
2004 Abstracts Presented at AHA:
Jani SM, Riba A, Goswami R, O'Donnell MJ, Smith DE, Khanal S, Patel K, Lauer M, Davis T, Share
D, Moscucci M. Predictors of Vascular Complications in Patients undergoing Percutaneous
Coronary Interventions in the Era of Vascular Closure Devices.
Khanal S, Henry Ford Hospital, Detroit, MI; DeFranco AC, McLaren Regional Medical Center, Flint,
MI; Smith DE, University of Michigan, Ann Arbor, MI; O'Donnell MJ, St. Joseph Mercy Hospital,
Ann Arbor, MI; Hill T, Mercy General Hospital, Muskegon, MI; Patel K, St. Joseph Mercy Hospital,
Oakland, MI; D'Haem C, Ingham Regional Medical Center, Lansing, MI; Share D, Blue Cross Blue
Shield of Michigan, Detroit, MI; Chandra H, Spectrum Health Butterworth Hospital, Grand Rapids,
MI; Moscucci M, University of Michigan, Ann Arbor, MI. Does Time of Symptom Onset to
Percutaneous Coronary Intervention Affect In-hospital Outcomes in Patients with Non-ST
elevation Myocardial Infarction?
Moscucci M, Smith DE, Jani SM, Montoye CK, University of Michigan, Ann Arbor, MI; DeFranco
AC, McLaren Regional Medical Center, Flint, MI; Chandra H, Spectrum Health Butterworth Hospital,
Grand Rapids, MI; Karve M, Sparrow Hospital, Lansing, MI; Share D, Blue Cross Blue Shield of
14
Michigan, Detroit, MI. Gender Differences in Time to Treatment for Patients Undergoing
Primary Percutaneous Coronary Intervention for Acute ST segment Elevation Myocardial
Infarction: An Important Target for Quality Improvement.
Moscucci M, Smith DE, Jani SM, Kline-Rogers E, University of Michigan, Ann Arbor, MI; DeFranco
AC, McLaren Regional Medical Center, Flint, MI; Davis T, St. Johns Hospital and Medical Center,
Detroit, MI; O'Donnell MJ, St. Joseph Mercy Hospital, Ann Arbor, MI; Zughaib M, Providence
Medical Center, Southfield, MI; Gencheff N, Marquette General Hospital, Marquette, MI; Share D,
Blue Cross Blue Shield of Michigan, Detroit, MI. Practice Variation and Adherence to
"Guidelines" with the Introduction of Drug Eluting Stents: Insights from a Large Multicenter
PCI Registry.
2004 Abstracts Presented at ACC:
Khanal S, Smith DE, Share D, Gardin J, Lauer M, Kline-Rogers E, Moscucci M, Henry Ford Hospital,
Detroit, MI, University of Michigan, Ann Arbor, MI. Clinical Outcomes of Elective Contemporary
Percutaneous Coronary Interventions in Octogenarians: Insights from the Blue Cross Blue
Shield of Michigan Cardiovascular Consortium (BMC2).
Khanal S, Attallah N, Smith DE, Kline-Rogers E, Moscucci M, Henry Ford Hospital, Detroit, MI,
University of Michigan, Ann Arbor, MI. Does Statin Therapy Reduce Contrast-Induced
Nephropathy? An Analysis from a Large Regional Registry of Contemporary Percutaneous
Interventions.
Goswami R, McGinnity JG, Riba AL, Montoye CK, Smith DE, Gardin J, O'Donnell MJ, DeFranco
AC, Share D, Moscucci M, for the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
(BMC2), University of Michigan, Ann Arbor, MI. Predictors of Vascular Complications in
Patients Undergoing Percutaneous Coronary Intervention and Treated with Vascular Closure
Devices.
Moscucci M, Smith DE, Riba A, Goswami R, DeFranco AC, Khanal S, O'Donnell M, Share D, Eagle
KA, for the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2), University of
Michigan, Ann Arbor, MI. Safety and Efficacy of Glycoprotein IIb/IIIa Receptor Blockers in
Patients with Chronic Renal Insufficiency Undergoing Contemporary Percutaneous Coronary
Intervention
2003 Abstracts Presented at AHA:
Mukherjee D, Eagle, KA, Smith D, Kline-Rogers E, Lins S, Draus C, Share D, Chetcuti S, Grossman
PM, Moscucci M. on behalf of the Blue Cross and Blue Shield of Michigan Consortium (BMC2).
Simple Risk Score for Predicting Mortality in Diabetic Patients Undergoing Percutaneous
Coronary Intervention.
Chetcuti SJ, Mukherjee D, Smith DE, Grossman PM, Bates ER, Duvernoy CJ, Eitzman DT, Moscucci
M. Development of a Continuous Quality Improvement Program for the Reduction of Contrast
Nephropathy after Percutaneous Coronary Intervention.
Moscucci M, Montoye C, Kline-Rogers E, Smith DE, Share D, O’Donnell M, DeFranco AC,
Maxwell-Eward A, Patel K, Meengs W, Khanal S, McGinnity JG, Eagle KE, for the Blue Cross Blue
Shield of Michigan Cardiovascular Consortium (BMC2). Improving Outcomes of Percutaneous
15
Coronary Interventions: The Blue Cross Blue Shield of Michigan Cardiovascular Consortium
(BMC2) Collaborative Quality Improvement Initiative in Percutaneous Coronary Interventions.
Montoye CK, Kline-Rogers EM, Smith DE, Garden J, Lauer M, DeFranco AC, Riba A, Kure J,
Gencheff N, D’Haem C, Karve M, Moscucci M. Quality of Care for AMI Patients Undergoing
Percutaneous Coronary Interventions (PCI) is Enhanced by Participation in the American
College of Cardiology (ACC) AMI Guidelines Applied in Practice Quality Improvement
Initiative.
Moscucci M, Smith DE, DeFranco AC, O’Donnell MJ, Meengs WL, McNamara RF, Lauer M, Riba
A, Gardin J, Khanal S, Share D, for the Blue Cross Blue Shield of Michigan Center for Health Quality.
Risk Adjustment and In-Hospital Mortality Following Coronary Intervention: A Moving
Target.
2003 Abstracts Presented at ACC:
Chetcuti, S, Grossman, P, Mukherjee D, Kline-Rogers, E, Montoye C, Share D, O’Donnell, M, Patel
K, Moscucci M, for the Blue Cross Blue Shield Michigan Cardiovascular :Consortium (BMC2).
Improving Outcome of Percutaneous Coronary Intervention through Application of Guidelines
and Benchmarking: Reduction of Blood Transfusion as a Model.
McKechnie R, Montoye C, Kline-Rogers E, O’Donnell M, DeFranco A, Meengs W, McNamara R,
McGinnity J, Patel K, Share D, Riba A, Moscucci M, for the Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2). Lower Preprocedural Hemoglobin Level is Associated with
Increased Risk of In-Hospital Mortality Following Percutaneous Coronary Intervention.
Moscucci M, Smith DE, Mukherjee D, Montoye C, O’Donnell M, DeFranco A, Meengs WL,
Maxwell-Eward A, McGinnity J, Patel K, Share D, for the Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2). Relationship Between Time of Day/Day of Week and
Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute
Myocardial Infarction.
2002 Abstracts Presented at ACC:
Moscucci M, DeFranco AC, Share D, O'Donnell M, Meengs WL, Maxwell-Eward A, McGinnity JG,
Patel K, Clark VL, Smith DE, Kline-Rogers E, Eagle KA, for the Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2). Low Body Mass Index is an Important Correlate of Fatal
and Nonfatal Complications after Percutaneous Coronary Interventions.
Moscucci M, Eagle KA, Share D, DeFranco AC, Vakili BA, Clark VL, Slater JN, Sherman W, Ravi
KL, Sanborn TA, Green SJ, Brown DL. Albert Einstein. Public Reporting and Case Selection for
Percutaneous Coronary Interventions: an Analysis from Two Large Multicenter PCI Databases.
Moscucci M, Smith DE, Share D, O'Donnell M, DeFranco AC, Meengs WL, Maxwell-Eward A,
McGinnity JG, Patel K, Clark VL, Kline-Rogers E, Bondie D, Eagle KE, for the Blue Cross Blue
Shield of Michigan Cardiovascular Consortium (BMC2), University of Michigan, Ann Arbor,
Michigan. Practice and Outcome Variations in Percutaneous Coronary Intervention: An
Analysis of a Large Multicenter PCI Database.
16
Moscucci M, Share D, O'Donnell M, DeFranco AC, Meengs WL, Maxwell-Eward A, McGinnity JG,
Patel K, Kline-Rogers E, Bondie D, Clark VL, Smith DE, Eagle KA, for the Blue Cross Blue Shield of
Michigan Cardiovascular Consortium (BMC2). Beneficial Effect of Glycoprotein IIb/IIIa Receptor
Blockers in Patients Undergoing Primary PCI for Cardiogenic Shock.
Moscucci M, Smith DE, Share D, O'Donnell M, DeFranco AC, Kline-Rogers E, Maxwell-Eward A,
McGinnity JG, Patel K, Clark VL, Meengs WL, Bondie D, Eagle KA, for the Blue Cross Blue Shield
of Michigan Cardiovascular Consortium (BMC2). Predictors of Length of Hospital Stay after
Contemporary Coronary Stenting.
Moscucci M, Kline-Rogers E, DeFranco AC, O'Donnell M, Maxwell-Eward A, Share D, McGinnity
JG, De Gregorio M, Meengs WL, Clark VL, Eagle KA, for the Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2). Effect of Pre-Procedure Lipid Lowering Therapy on InHospital Mortality Following Percutaneous Coronary Interventions: An Analysis of a Large
Multicenter Database.
2002 Abstracts Presented at AHA:
Mukherjee D, Eagle KA, Smith DE, Kline-Rogers EM, O'Donnell M, De Franco A, Maxwell-Eward
A, McGinnity J, Meengs WM, Patel K, Moscucci M. Prognostic Implications of Extra-Cardiac
Vascular Disease in Patients Undergoing Coronary Interventions: Insights from the Blue Cross
Blue Shield of Michigan Consortium (BMC2).
Moscucci M, Smith DE, University of Michigan, O'Donnell MJ, St. Joseph Mercy Hospital, DeFranco
AC, McLaren Regional Medical Center, Meengs WL, Northern Michigan Hospital, Maxwell-Eward A,
Spectrum Health, McGinnity JG, Harper University Hospital, Patel K, St. Joseph Mercy Hospital,
Oakland, Share D, Blue Cross Blue Shield of Michigan. Relationship Between Low Operator
Volume and Adverse Outcome in Contemporary PCI Practice: An Analysis of a Large Quality
Controlled Multicenter PCI Database.
2001 Abstracts Presented at ACC:
Moscucci M, Share D, Kline-Rogers EM, O'Donnell MJ, Greenbaum AB, Meengs WL, MaxwellEward A, DeFranco AC, Eagle KA, for the Blue Cross Blue Shield of Michigan Cardiovascular
Consortium (BMC2). Blood Transfusion after Percutaneous Coronary Interventions: A Potential
Target for Quality Improvement.
Moscucci M, Eagle KA, Share D, DeFranco AC, Vakili BA, Clark VL, Slater JN, Sherman W, Ravi
KL, Sanborn TA, Green SJ, Brown DL, Albert. Public Reporting and Operator Volume Standards
for Percutaneous Transluminal Coronary Interventions in South East Michigan: Regional
Trends toward the High Volume Concept.
Moscucci M, Malenka DJ, Wennberg DE, Share D, O'Donnell MJ, DeFranco AC, Kline-Rogers E,
Greenbaum AB, Maxwell-Eward A, Meengs WL, Eagle KA. Potential Bias in the use of Combined
End Points in Quality Assessment of Percutaneous Coronary Interventions: An Analysis of the
Relationship between History of Prior CABG and MACE.
2001 Abstracts Presented at AHA:
17
DeFranco AC, Bates E, Meengs WL, O’Donnell M, Share D, McGinnnity J, Maxwell-Eward A, Clark
V, Patel K, Moscucci M. Transfer Status for Emergency Percutaneous Coronary Interventions:
an Important Predictor of Worse Prognosis.
Moscucci M, Share D, Maxwell-Eward A, O’Donnell M, Kline-Rogers E, DeFranco AC, Meengs WL,
Clark V, McGinnity L, DeGregorio M, Eagle KA. Emergency CABG Following Percutaneous
Coronary Interventions for Acute Myocardial Infarction: Current Frequency and Prognosis.
Moscucci M, Piper WD, O’Connor GT, O’Donnell M, Share D, Malenka DJ. Validation of a Risk
Prediction Rule for Vascular Complications of Percutaneous Coronary Interventions on a Large
Independent Dataset.
2000 Abstracts Presented at ACC:
Moscucci M, Share D, O’Donnell MJ, Maxwell-Eward A, Chambers JL, Meengs WL, Kraft P, KlineRogers E, Patel K, McGinnity J, Eagle KA. A Simple Mortality Risk Tool for Individual Patients
Undergoing Percutaneous Coronary Interventions: A Report from the Blue Cross Blue Shield of
Michigan Cardiovascular Consortium (BMC2).
2000 Abstracts Presented at AHA:
Moscucci M, Chambers JL, Dabbous SA, Eagle KA, Karavite D, Kline-Rogers E, Kraft P MaxwellEward A, Meengs WL, O’Donnell M, Patel K, Share D, Zoltan T. Risk Adjustment Models for
Adverse Outcomes and Benchmarking in Interventional Cardiology: A Report from the Blue
Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
1999 Abstracts Presented at ACC:
Moscucci M, Chambers JL, Dabbous SA, Eagle KA, Karavite D, Kline Rogers E, Kraft P, MaxwellEward A, Meengs WL, O'Donnell MJ, Patel K, Share D, Turi Z. Risk Adjustment Models for
Adverse Outcomes and Benchmarking in Interventional Cardiology: A Report from the Blue
Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
1999 Abstracts Presented at AHA:
Freeman RV, Share D, Maxwell-Eward A, O’Donnell MJ, Kraft P, Meengs WL, Chambers JL,
Bruckman D, Kline-Rogers E, Eagle KA, Moscucci M. Nephropathy Requiring Dialysis after
Percutaneous Coronary Interventions: A Simple Prediction Rule for a Rare Complication
Carrying a Grim Prognosis. A Study from the Blue Cross Blue Shield of Michigan
Cardiovascular Consortium (BMC2).
O’Donnell MJ, Meengs WL, Maxwell-Eward A, Kraft P, Chambers JL, Share D, Kline-Rogers E,
Moscucci M. The Clinical Paradox of Worse Outcomes with Adjunctive Abciximab in the
Setting of Percutaneous Transluminal Coronary Interventions: A Report from the Blue Cross
Blue Shield of Michigan Cardiovascular Consortium (BMC2).
18